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Introduction: Endotracheal suctioning (ETS) is essential for patient care in an ICU but may represent a cause of
cerebral secondary injury. Ketamine has been historically contraindicated for its use in head injury patients, since
an increase of intracranial pressure (ICP) was reported; nevertheless, its use was recently suggested in neurosurgical
patients. In this prospective observational study we investigated the effect of ETS on ICP, cerebral perfusion
pressure (CPP), jugular oxygen saturation (SjO2) and cerebral blood flow velocity (mVMCA) before and after the
administration of ketamine.
Methods: In the control phase, ETS was performed on patients sedated with propofol and remifentanil in
continuous infusion. If a cough was present, patients were assigned to the intervention phase, and 100 γ/kg/min
of racemic ketamine for 10 minutes was added before ETS.
Results: In the control group ETS stimulated the cough reflex, with a median cough score of 2 (interquartile
range (IQR) 1 to 2). Furthermore, it caused an increase in mean arterial pressure (MAP) (from 89.0 ± 11.6 to
96.4 ± 13.1 mmHg; P <0.001), ICP (from 11.0 ± 6.7 to 18.5 ± 8.9 mmHg; P <0.001), SjO2 (from 82.3 ± 7.5 to 89.1 ± 5.4;
P = 0.01) and mVMCA (from 76.8 ± 20.4 to 90.2 ± 30.2 cm/sec; P = 0.04). CPP did not vary with ETS. In the
intervention group, no significant variation of MAP, CPP, mVMCA, and SjO2 were observed in any step; after ETS,
ICP increased if compared with baseline (15.1 ± 9.4 vs. 11.0 ± 6.4 mmHg; P <0.05). Cough score was significantly
reduced in comparison with controls (P <0.0001).
Conclusions: Ketamine did not induce any significant variation in cerebral and systemic parameters. After ETS,
it maintained cerebral hemodynamics without changes in CPP, mVMCA and SjO2, and prevented cough reflex.
Nevertheless, ketamine was not completely effective when used to control ICP increase after administration of
100 γ/kg/min for 10 minutes.Introduction
Endotracheal suctioning (ETS) is essential for patient care
in an intensive care unit, but may represent a cause of
cerebral secondary injury. In the last few years, several
authors found that it can have considerable negative im-
pact on cerebral physiologic variables, causing coughing,
increasing intracranial pressure (ICP) and altering cerebral
perfusion pressure (CPP) in head-injured patients [1-5].
With the aim of controlling cerebral and systemic effects
related to ETS, a lot of studies have been conducted to test
different drugs or procedures, such as hyperventilation* Correspondence: anselmo.caricato@rm.unicatt.it
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reproduction in any medium, provided the or[6], administration of opioids [7-10], barbiturates [8], local
anesthetics [8,11-13], and paralyzing agents [7,8]. Unfortu-
nately, in many cases single-center nonrandomized clinical
studies were performed, based on small samples, thus
leading to conclusions with low level of scientific evidence.
Even if recent recommendation for ETS in mechanically
ventilated patients are available [14], so far no consensus
exists about which strategy should be used to reduce intra-
cranial effects of this procedure.
Ketamine is an N-methyl-D-aspartate receptor antagonist
recommended during minor procedures, for the induction
of anesthesia prior to the administration of other agents,
and to supplement low-potency anesthetics. It has unique
properties as a dissociative anesthetic, analgesic, amnestic
and anxiolytic; it exerts its effect by ‘disconnecting’ thel Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Study protocol
Study protocol
T1 Baseline
T2 Immediately before ETS
T3 Immediately after ETS
T4 5 minutes after ETS
T5 10 minutes after ETS
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the central nervous system from outside stimuli [15,16].
The result is a ‘dissociative anesthesia’, that is character-
ized by analgesia, amnesia and anxiolysis, while maintain-
ing cardiovascular stability and preserving spontaneous
respirations and protective airway reflexes [15,16].
It has been historically contraindicated for its use in
patients with head injury because of a concern that it
may increase ICP [17-21]. However, several recent stud-
ies suggested ketamine as a sedative in the setting of a
neurosurgical intensive care unit, since no association
was observed between ketamine and ICP in mechanic-
ally ventilated head-injured patients during continuous
analgosedation [22-29].
Thus, it has officially been recommended for use in
analgesia and sedation in European countries.
Furthermore, several animal studies observed its neuro-
protective activity against hypoxic, ischemic or mechanical
neuronal insults [29].
We hypothesized that ketamine could be safe and
effective in blunting ICP increase after ETS in these
patients.
Thus, we investigated the effect of ETS before and
after ketamine on ICP, CPP, jugular oxygen saturation
(SjO2) and cerebral blood flow velocity in head-injured
patients during continuous infusion of propofol and
remifentanil.
Material and methods
Patients and data collection
After approval by the Ethics Committee of the Catholic
University School of Medicine (P/997/CE/2010), informed
written consent was obtained from patients’ next of kin.
Inclusion criteria were:
 Age between 18 and 75 years
 Severe closed head-injured patients (GCS ≤8)
within 72 hours after trauma
 ICP monitoring
 Analgesia and sedation with propofol
(3 to 5 mg/kg/h) and remifentanil (0.05 to 2 γ/kg/min)
in continuous infusion to obtain a Ramsey score
of 5 to 6
Exclusion criteria were:
 Severe hemodynamic instability
 Paralyzed patients
 Known allergy to the treatment drugs or pregnancy
Patients were managed according to Brain Trauma
Foundation Guidelines [30]. Multimodal monitoring, in-
cluding ICP and SjO2 was performed (SC7000 Monitor,
Siemens, Erlangen, Germany). Patients were mechanicallyventilated in volume-controlled ventilation, thus to main-
tain partial pressure of carbon dioxide in the blood
(paCO2) between 32 and 35 mmHg and partial pressure
of oxygen in the blood (paO2) >70 mmHg.
Jugular bulb catheters were inserted in the larger inter-
nal jugular vein, under ultrasonographic control; correct
position was verified by X-rays.
Patients were nursed supine with a 30° head-up tilt.
Blood flow velocity in the middle cerebral artery (mV
MCA) was measured by 2 MHz pulsed Doppler ultra-
sound device (transcranial Doppler (TCD) H21-Hitachi
Medical Systems Europe, Zug, Switzerland).
Study protocol
The study was structured in two phases: control and
intervention. In the control phase, patients were sedated
with propofol (3 to 5 mg/kg/h) and remifentanil (0.05 to
0.2 γ/kg/min) in continuous infusion, and ETS was per-
formed according to recent guidelines through an oro-
tracheal tube [14]. If cough was present, patients were
assigned to the intervention phase, and an infusion of a
racemic mixture of ketamine 100 γ/kg/min for 10 minutes
was added before ETS.
In both phases, each patient underwent the protocol
as described in Table 1. At each step, a standard set of
parameters was recorded: heart rate (HR), mean arterial
pressure (MAP), ICP, CPP. In addition, at step 1, 3 and
5, arterial blood gas analysis and SjO2 were carried out;
at these steps, mV MCA was bilaterally measured by
TCD, and mean value was reported. In the control
phase, step 2 was not carried out.
An evaluation of cough strength was performed after
ETS by a semi-quantitative scale (Harris Scale; component
‘Response to endotracheal suctioning’) [31]. It ranged
between 1 and 4 (Table 2).
Statistical analysis
Repeated measures analysis of variance was used in
order to study physiologic parameters before, during and
after ETS. Cough reflex after ETS was evaluated by the
Friedman test for repeated measures; in cases of multiple
comparisons, level of significance was adjusted using the
Bonferroni correction, and corrected P value was repor-
ted. Statistical calculations were performed using the
Statistical Package for Social Sciences (Windows version
Table 2 Scoring of cough strength [31]
Cough strength
1 Agitation, distress, prolonged coughing
2 Coughs, distressed, rapid recovery
3 Coughs, not distressed
4 No cough
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reported as mean ± standard deviation, or median and
interquartile range (IQR), as appropriated; a value of
P <0.05 was considered statistically significant.
Results
Twenty-one head-injured patients consecutively admitted
to 18-bed general ICU of ‘A. Gemelli’ Hospital between 1
January 2011 and 1 November 2011 were enrolled in the
study. ‘A. Gemelli’ Hospital is a 1,200-bed university
hospital located in Rome, Italy, that is a referral center for
severely injured patients and serves an urban area of 1
million people.
During baseline analgosedation (control group), a
cough reflex was present in all patients, and all were
included in the study.
The sample was predominantly male (57%), with
nine females (43%). The mean age was 54.6 ± 21.2,
ranging from 19 to 74 yrs. The patients’ severity of
illness, as measured by the Glasgow Coma Scale (5.8 ± 3.8)
and the Simplified Acute Physiology Score II (SAPS II)
score (49.7 ± 9.2), showed severe injuries and signifi-
cant comorbidities requiring high levels of medical
and nursing care. At baseline, ICP was always below
25 mmHg. During the study, hyperventilation was not
applied, and five patients were treated with hyperos-
molar therapy.60
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Figure 1 Ketamine prevented any significant increase of mean arteria
significance in comparison with T1 is shown. *P <0.05; **P <0.01.Control
Despite deep sedation, ETS (T3) caused an increase of
HR (from 74.3 ± 14.0 to 82.1 ± 17.6 min-1; P <0.001),
MAP (from 89.0 ± 11.6 to 96.4 ± 13.1 mmHg; P <0.001),
ICP (from 11.0 ± 6.7 to 18.5 ± 8.9 mmHg; P <0.001),
SjO2 (from 82.3 ± 7.5 to 89.1 ± 5.4%; P = 0.01) and mV
MCA (from 76.8 ± 20.4 to 90.2 ± 30.2 cm/sec; P =0.04) if
compared with T1. CPP did not vary with ETS (Figures 1,
2, 3, 4 and 5). Furthermore, ETS stimulated a strong
cough reflex, with a median cough score of 2 (IQR 1 to 2)
(Figure 6).
These changes were not sustained over time. As
compared with T1, 10 minutes after ETS (T5) HR (from
74.3 ± 14.0 to 78.0 ± 20.4 min-1; P = 0.17), MAP (from
89.0 ± 11.6 to 88.8 ± 11.0 mmHg; P = 0.92), ICP (from
11.0 ± 6.7 to 11.4 ± 7.4 mmHg; P = 0.61) and SjO2 (from
82.3 ± 7.5 to 85.1 ± 6.0%; P = 0.13) were not modified;
mV MCA increased (from 76.8 ± 20.4 to 84.6 ± 24.2;
P = 0.03) (Figures 1, 2, 3, 4 and 5).Intervention
No significant variation of HR, MAP, CPP, mV MCA,
and SjO2 were observed in any step during the study. At
baseline (T1) ICP was 11.0 ± 6.4 mmHg; at this step, in
two cases it was higher than 20 mmHg. Following keta-
mine administration (T2), ICP did not modify (11.7 ± 7.3
vs. 11.0 ± 6.4 mmHg; P = 0.28); after ETS (T3) cough
reflex was significantly reduced in comparison with con-
trols (cough score 4 (IQR 3 to 4) vs. 2 (IQR1 to 2);
P <0.0001) (Figure 6). ICP increased after ETS if com-
pared with T1 (15.1 ± 9.4 vs. 11.0 ± 6.4 mmHg; P <0.05).
(Figures 1, 2, 3, 4 and 5). Interestingly, in contrast with
controls, ETS did not induce any significant change of
mV MCA and SjO2.t4 t5
Controls
Keta
*
P
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50
55
60
65
70
75
80
85
90
95
100
t0 t1 t3 t4 t5
Controls
Keta
CPP
mmHg
Figure 2 No significant difference in cerebral perfusion pressure (CPP) was observed during the study in both groups.
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The main result of this study is that the administration
of a racemic mixture of ketamine did not induce any sig-
nificant variation of ICP, CPP, MAP, mV MCA and SjO2
in mechanically ventilated head-injured patients during
continuous analgosedation. If administered before ETS,
racemic ketamine reduced cough reflex, and prevented
any significant change of MAP, CPP, mV MCA and SjO2
in comparison with controls. Nevertheless, its use before
ETS was not sufficient to completely blunt ICP increases
at the drug dose studied.
Ketamine has been historically contraindicated for its
use in patients with head injury, since an association
with increased ICP was reported [17-21]. This concept
originated from a few case reports and small case–con-
trol studies from the 1970s conducted on patients with
abnormal cerebrospinal fluid pathways. The increase of
ICP was observed in patients who were breathing spon-
taneously and who had received ketamine as a sole
anesthetic agent. It was thought to be related to an in-
crease in cerebral metabolic rate and to a corresponding
increase of cerebral blood flow.
However, several articles are challenging this message
[22-29]. Mayberg et al. investigated cerebral hemodynamics5
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Figure 3 Differences between control and intervention in intracranial
in comparison with T1 is shown. *P <0.05; **P <0.01.in 20 patients undergoing craniotomy after induction of
isoflurane/nitrous oxide anesthesia [23]. They found that an
intravenous bolus of 1 mg/kg ketamine did not modify
MAP, CPP and arterojugular difference of oxygen, while
ICP and mV MCA were significantly reduced. Albanese
et al. confirmed these data [24]. In patients with severe
head injury who were sedated with propofol, they found
that ICP decreased after increasing doses of intravenous
ketamine boluses, and no significant differences in MAP,
CPP, SjO2, and mV MCA were observed. Recently, Bar-
Joseph found that a single ketamine dose decreased ICP by
30% (from 25.8 ± 8.4 to 18.0 ± 8.5 mm Hg; P <0.001) and
increased CPP from 54.4 ± 11.7 to 58.3 ± 13.4 mm Hg
(P <0.005) during analgosedation in pediatric mechanically
ventilated head-injured patients [22].
Reasons for these conflicting results are not completely
known. In particular, effects of ketamine on cerebral blood
flow (CBF) and cerebral metabolic rate (CMR) are equivo-
cal, since they varied in different brain regions, according
to the type of ketamine used (racemic, S-, or R- enantio-
mers) and the dose administered. According to positron
emission tomography (PET) studies by Vollenweider,
subanesthetic doses (0.2 to 0.3 mg/kg) of S-ketamine
increased CMR, whereas R-ketamine decreased it [32].Controls
Keta
             t4                   t5   
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Figure 4 A significant increase of blood flow velocity in the middle cerebral artery (mV MCA) was observed in the control group.
Statistical significance in comparison with T1 is shown. *P <0.05.
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ing the administration of a large (10 mg/kg) dose of
racemic ketamine [33].
Also, the observed increase in CBF may be partly
mediated by a direct effect of the drug on arterial pres-
sure, and partly by a concomitant increase in PaCO2 in
spontaneously breathing patients.
Simultaneous administration of propofol or benzodiaz-
epines, and mechanical ventilation may blunt these
changes in CBF, and explain the results of recent studies.
At present, the use of ketamine in neurosurgical patients
is not considered completely safe. Even if it is recom-
mended in some countries for analgesia and sedation in78
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t1                              t3          
*
SjO2
Figure 5 SjO2 increased after endotracheal suctioning (ETS) in both g
Statistical significance in comparison with T1 is shown. *P <0.05.head-injured patients, the Federal Drug Administration
(FDA) suggests its use with extreme caution in patients
with preanesthetic elevated cerebrospinal fluid pressure.
The Italian Authority for Drugs (AIFA) contraindicate its
use in patients with head injury [34]. Recent guidelines on
dealing with sedation and anesthesia for traumatic brain
injury do not mention it [30].
Our work provides support not only for the absence of
any significant variation of ICP after ketamine, but also
for the stability of mV MCA and SjO2. In addition, we
observed that the sedative effects of ketamine might be
useful as an adjunct to continuous analgosedation for
blunting cerebral and systemic response after ETS.Controls
Keta
                 t5   
roups. In the control group a significant difference was observed.
Controls Keta
Response to endotracheal suctioning
Cough 
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1
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4
Figure 6 Cough score evaluated after endotracheal suctioning (ETS) is shown [31]. Each bar corresponds to the cough score of each patient.
Caricato et al. Critical Care 2013, 17:R267 Page 6 of 8
http://ccforum.com/content/17/6/R267Intracranial effects of ETS have been extensively
studied.
Several authors suggested that vasodilation occurs
during ETS, with a resulting increase in CBF that is
partially responsible for the increase in ICP [2,35,36].
Cruz found that ETS increased MAP and ICP, with a
concomitant increase in SjO2 and mV MCA, suggesting
a systemic and cerebral response to painful stimulus
[37]. In addition, coughing may induce an increase of
intrathoracic pressure and central venous pressure that
may contribute to ICP elevation [38].
Our data confirm these results. Despite analgoseda-
tion, ETS caused an increase of MAP associated with an
elevation of mV MCA and SjO2, as in the presence of an
increase of CBF. ICP significantly increased, but came
back to baseline after 10 minutes. This transient increase
in ICP after ETS may be due to the fact that intracranial
hypertension was not common in our patients. Actually,
mV MCA was significantly increased, and it remained
high during all the study. Unfortunately, we did not
measure CBF, but it is reasonable that in patients with
an altered intracranial compliance, the increase of CBF
may induce a severe increase of ICP.
After ketamine, cough reflex was significantly reduced
with respect to controls. In the same way, we observed
only an increase of ICP, in absence of any significant
variation of systemic and cerebral parameters. During
ICP increase, MAP did not modify, and CPP showed a
slight and nonsignificant reduction. In contrast with
what we observed in controls, we did not find any sig-
nificant variation of mV MCA and SjO2, suggesting that
ketamine could have prevented the increase of CBF in-
duced by ETS.
These data were in accord with Bar-Joseph, who ob-
served that ketamine reduced ICP in 88% of cases during
a potentially distressing intervention such as respiratory
physiotherapy, endotracheal suctioning or bed linen
change [22]. They did not study a standardized noxious
stimulus, as we did, and probably cerebral effects were
related to a less painful procedure.Nevertheless, their results refute the notion that keta-
mine could increase ICP, suggesting that ketamine could
induce an additional anesthetic effect without decrease
of CPP.
We are aware that this study has some limitations. In
fact, it was observational, monocentric and conducted
on a small number of patients. Furthermore intracranial
hypertension was not common in our cases and we did
not know in how many cases autoregulation was im-
paired. Probably, cerebral effects of ETS after ketamine
could be different in those subset of patients.
We used ketamine at a dose of 100 γ/kg/min for 10 mi-
nutes before ETS to minimize hemodynamic variation
due to rapid infusion. Actually, this dose can be low for
clinical effects; moreover, because of its brief half-life,
this slow infusion rate may lead to a less effective action
of the drug.
Conclusions
In conclusion, our data showed that racemic ketamine
did not induce any significant variation in cerebral and
systemic parameters in mechanically ventilated head-
injured patients during continuous analgosedation. After
ETS, ketamine maintained cerebral hemodynamics with-
out changes in CPP, mV MCA and SjO2, and prevented
cough reflex. Nevertheless, it was not effective enough
to control ICP increase.
Further studies should be encouraged to confirm these
results, in order to update indications of ketamine in
neurosurgical patients, and to recommend the best strat-
egy to control cerebrovascular effects after ETS.
Key messages
 Ketamine did not induce any significant variation of
ICP, CPP, MAP, mV MCA and SjO2 in mechanically
ventilated head-injured patients during continuous
analgosedation
 Despite continuous infusion of analgosedation,
endotracheal suctioning stimulated cough reflex and
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and ICP.
 If added to continuous analgosedation before
endotracheal suctioning, ketamine reduced cough
reflex, and prevented any significant change of
MAP, CPP, mV MCA and SjO2
 Ketamine was not sufficient to completely blunt
ICP increases after endotracheal suctioning.
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